Literature DB >> 27027323

Age and education-matched cut-off scores for the revised German/Swiss-German version of ECAS.

Markus Loose1, Christian Burkhardt2, Helena Aho-Özhan1, Jürgen Keller1, Susanne Abdulla3,4, Sarah Böhm1, Katja Kollewe3, Ingo Uttner1, Sharon Abrahams5, Susanne Petri3, Markus Weber2, Albert C Ludolph1, Dorothée Lulé1.   

Abstract

The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) has been developed to assess cognition and behaviour in patients with amyotrophic lateral sclerosis (ALS). Cognitive impairments of ALS-specific and ALS-non-specific functions can be determined using cut-off scores based on performance of healthy subjects. However, detailed analyses show that older healthy subjects perform worse than younger ones, whereas highly-educated individuals perform better than those with lower education levels. As a consequence, this study presents new age and education matched cut-off scores for the revised German/Swiss-German version of the ECAS based on the performance of 86 healthy subjects.

Entities:  

Keywords:  ECAS; German; amyotrophic lateral sclerosis; cognition; cut-off; executive; stratified; validation

Mesh:

Year:  2016        PMID: 27027323     DOI: 10.3109/21678421.2016.1162814

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  10 in total

1.  Multimodal in vivo staging in amyotrophic lateral sclerosis using artificial intelligence.

Authors:  Anna Behler; Hans-Peter Müller; Kelly Del Tredici; Heiko Braak; Albert C Ludolph; Dorothée Lulé; Jan Kassubek
Journal:  Ann Clin Transl Neurol       Date:  2022-06-09       Impact factor: 5.430

2.  Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches.

Authors:  Corey T McMillan; Joanne Wuu; Katya Rascovsky; Stephanie Cosentino; Murray Grossman; Lauren Elman; Colin Quinn; Luis Rosario; Jessica H Stark; Volkan Granit; Hannah Briemberg; Sneha Chenji; Annie Dionne; Angela Genge; Wendy Johnston; Lawrence Korngut; Christen Shoesmith; Lorne Zinman; Sanjay Kalra; Michael Benatar
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2022-03-07       Impact factor: 3.528

3.  Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS).

Authors:  Christopher Crockford; Judith Newton; Katie Lonergan; Caoifa Madden; Iain Mays; Meabhdh O'Sullivan; Emmet Costello; Marta Pinto-Grau; Alice Vajda; Mark Heverin; Niall Pender; Ammar Al-Chalabi; Orla Hardiman; Sharon Abrahams
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-12-07       Impact factor: 4.092

4.  Screening for Cognitive Function in Complete Immobility Using Brain-Machine Interfaces: A Proof of Principle Study.

Authors:  Dorothée Lulé; Katharina Hörner; Cynthia Vazquez; Helena Aho-Özhan; Jürgen Keller; Martin Gorges; Ingo Uttner; Albert C Ludolph
Journal:  Front Neurosci       Date:  2018-08-15       Impact factor: 4.677

5.  Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS.

Authors:  Jenna M Gregory; Karina McDade; Thomas H Bak; Suvankar Pal; Siddharthan Chandran; Colin Smith; Sharon Abrahams
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-09-12       Impact factor: 10.154

6.  SPG7 mutations in amyotrophic lateral sclerosis: a genetic link to hereditary spastic paraplegia.

Authors:  Alma Osmanovic; Maylin Widjaja; Alisa Förster; Julia Weder; Mike P Wattjes; Inken Lange; Anastasia Sarikidi; Bernd Auber; Peter Raab; Anne Christians; Matthias Preller; Susanne Petri; Ruthild G Weber
Journal:  J Neurol       Date:  2020-05-23       Impact factor: 4.849

7.  Sensitivity and Specificity of the ECAS in Parkinson's Disease and Progressive Supranuclear Palsy.

Authors:  Jennifer A Foley; Elaine H Niven; Andrew Paget; Kailash P Bhatia; Simon F Farmer; Paul R Jarman; Patricia Limousin; Thomas T Warner; Huw R Morris; Thomas H Bak; Sharon Abrahams; Lisa Cipolotti
Journal:  Parkinsons Dis       Date:  2018-05-09

8.  Neuronal clusterin expression is associated with cognitive protection in amyotrophic lateral sclerosis.

Authors:  J M Gregory; E Elliott; K McDade; T Bak; S Pal; S Chandran; S Abrahams; C Smith
Journal:  Neuropathol Appl Neurobiol       Date:  2019-08-28       Impact factor: 8.090

9.  Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers-a developmental disorder.

Authors:  Dorothée E Lulé; Hans-Peter Müller; Julia Finsel; Patrick Weydt; Antje Knehr; Ivar Winroth; Peter Andersen; Jochen Weishaupt; Ingo Uttner; Jan Kassubek; Albert C Ludolph
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-08-27       Impact factor: 10.154

10.  Eye movement alterations in presymptomatic C9orf72 expansion gene carriers.

Authors:  Dorothée Lulé; Jan Kassubek; Anna Behler; Antje Knehr; Julia Finsel; Martin S Kunz; Christina Lang; Kathrin Müller; Hans-Peter Müller; Elmar H Pinkhardt; Albert C Ludolph
Journal:  J Neurol       Date:  2021-03-11       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.